BeyondSpring competitorsClear all

Omeros's top competitors include Athersys and Otonomy.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Omeros
Omeros
Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers.
Athersys
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Otonomy
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Founding Date
Founding Date
1994
Founding Date
1995
Founding Date
2008
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Seattle, US HQ
Locations
Cleveland, US HQ
Canton, US
Locations
San Diego, US HQ
Employees
Employees
2777% increase
Employees
8311% increase
Employees
49
Valuation ($)
Valuation ($)
512.2 m
Valuation ($)
289.6 m
Valuation ($)
120.7 m
Twitter followers
Twitter followers
336
Twitter followers
2.3 k
Twitter followers
208
Alexa Website Rank
Alexa Website Rank
276762
Alexa Website Rank
151761
Alexa Website Rank
116688
Employee Rating
Employee Rating
3.5
Employee Rating
4.4
Employee Rating
4.3

Financial

Revenue (est.)
Revenue (est.)
$73.8m (FY, 2020)
Revenue (est.)
$1.4m (FY, 2020)
Revenue (est.)
$273k (FY, 2020)
Cost of goods
Cost of goods
$902k (FY, 2020)
Cost of goods
N/A
Cost of goods
$1.2m (FY, 2020)
Gross profit
Gross profit
$72.9m (FY, 2020)
Gross profit
N/A
Gross profit
($915k) (FY, 2020)
Net income
Net income
($138.1m) (FY, 2020)
Net income
($78.8m) (FY, 2020)
Net income
($44.7m) (FY, 2020)

Operating

Patents (US)
Patents (US)
82 (FY, 2020)
Patents (US)
21 (FY, 2016)
Patents (US)
N/A
Patents Issued
Patents Issued
N/A
Patents Issued
200 (FY, 2016)
Patents Issued
88 (FY, 2016)
Phase I Trials Products
Phase I Trials Products
2 (FY, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
1 (FY, 2016)
Phase II Trials Products
Phase II Trials Products
2 (FY, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
2 (FY, 2016)
Phase III Trials Products
Phase III Trials Products
3 (FY, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
2 (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 354.8m
Total funding raised
$ 9m
Total funding raised
$ 153.4m
For sources of this data, please see the company profile

View company profiles

Athersys
HQ
Cleveland, US
Employees
83↑ 11% increase

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company
Otonomy
HQ
San Diego, US
Employees
49

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.

View company